← Leaderboards
Shantha T Raju
Venn Therapeutics, Llc
$225,000
Attributed
$225,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$225,000 · 1
By mechanism
R43$225,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Anti-Tumor Immune Response”
- Crystal Mackall · Children'S Hosp Of Philadelphia$8,362,873
- Gary Fanger · Rise Therapeutics, Llc$7,793,544
- Nicholas Arpaia · Columbia Univ New York Morningside$7,790,111
- Zachary Scott Morris · University Of Wisconsin-Madison$6,871,026
- Kian H Lim · Washington University$4,040,151
- Sana D Karam · University Of Colorado Denver$3,856,392
Research focus
Anti-Tumor Immune ResponseBaseBcl9 GeneBeta CateninCancer ImmunotherapyCancer ModelCancer PatientCancer TherapyCancer TypeCarcinogenesisCell LineCell ProliferationCellsCell SurvivalCharacteristicsCofactorColon Cancer Cell LineColon CarcinomaColorectal CancerColorectal Cancer TreatmentCytotoxic T-LymphocytesDendritic CellsDrug KineticsAnalog